Clinical Outcome

P-24.2.2 - Labral Tear Management in Patients Aged 40 Years and Older Undergoing Primary Hip Arthroscopy

Authors
Speaker
Disclosure
Financial interests: Amplitude, Arthrex, ATI, Breg, DJO Global, Kauffman Foundation, MAKO Surgical, Medacta, Medwest, Orthomerica, Pacira Pharmaceuticals, Stryker Affiliations: American Hip Institute, Hinsdale Orthopaedics, North Shore Surgical Suites,
Presentation Topic
Clinical Outcome
Poster Rating
 | 

Previous ePoster
P-24.2.1 - Comparison of Safety and Efficacy Between Autologous PRP and Cordonal PRP in the Treatment of Hip OA

Next ePosters
P-24.2.3 - dGEMRIC Analysis of Neoacetabular and Acetabular Cartilage of Patients with Developmental Dysplasia of the Hip
P-24.2.4 - Minimum 10-Year Follow-Up Outcomes and Survivorship Following Primary Hip Arthroscopy with Acetabular Microfracture
P-24.2.5 - Athletes Given Capsular Repair Have Successful Outcomes: A Propensity-Matched Analysis with Minimum 2-Year Follow-Up
P002 - Comparison of Three Cell-Free Matrix Scaffolds Used to Treat Osteochondral Lesions in a Rabbit Model
P003 - Volumetric Growth of Distal Femoral Cartilage and Bone during Murine Postnatal Development follows Gompertz Law
P004 - A Protocol for Single-Cell Sequencing the Cell Populations Within the Murine Knee
P005 - High-level of expansion combined with IL-1β treatment accelerates development of chondrosenescent phenotype
P006 - Establishment of an Ex Vivo Model of Inflammatory Osteoarthritis with Human Osteochondral Explants
P007 - In Vitro Modelling of Human Cartilage: Comparing Traditional Culture Methods with Pregenerate Organ-on-a-Chip System
P009 - Development of a Human Synovial Joint-on-a-Chip Model